Market closedNon-fractional
SI-BONE/SIBN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About SI-BONE
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Ticker
SIBN
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Santa Clara, United States
Employees
344
Website
si-bone.com
SI-BONE Metrics
BasicAdvanced
$658M
Market cap
-
P/E ratio
-$1.08
EPS
1.20
Beta
-
Dividend rate
Price and volume
Market cap
$658M
Beta
1.2
Financial strength
Current ratio
9.761
Quick ratio
8.635
Long term debt to equity
22.532
Total debt to equity
23.398
Interest coverage (TTM)
-13.60%
Management effectiveness
Return on assets (TTM)
-15.99%
Return on equity (TTM)
-33.23%
Valuation
Price to revenue (TTM)
4.427
Price to book
3.98
Price to tangible book (TTM)
3.98
Price to free cash flow (TTM)
-27.929
Growth
Revenue change (TTM)
23.46%
Earnings per share change (TTM)
-32.11%
3-year revenue growth (CAGR)
23.21%
3-year earnings per share growth (CAGR)
-8.64%
What the Analysts think about SI-BONE
Analyst Ratings
Majority rating from 9 analysts.
SI-BONE Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$38M
-2.58%
Net income
-$11M
-0.00%
Profit margin
-28.83%
2.63%
SI-BONE Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.30
-$0.25
-$0.27
-$0.27
-
Expected
-$0.40
-$0.34
-$0.28
-$0.31
-$0.27
Surprise
-24.36%
-27.06%
-3.44%
-12.75%
-
SI-BONE News
AllArticlesVideos
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
GlobeNewsWire·2 weeks ago
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
GlobeNewsWire·2 months ago
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SI-BONE stock?
SI-BONE (SIBN) has a market cap of $658M as of July 27, 2024.
What is the P/E ratio for SI-BONE stock?
The price to earnings (P/E) ratio for SI-BONE (SIBN) stock is 0 as of July 27, 2024.
Does SI-BONE stock pay dividends?
No, SI-BONE (SIBN) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next SI-BONE dividend payment date?
SI-BONE (SIBN) stock does not pay dividends to its shareholders.
What is the beta indicator for SI-BONE?
SI-BONE (SIBN) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell SI-BONE stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.